CUTC
gene geneOn this page
Also known as CGI-32
Summary
CUTC (cutC copper transporter, HGNC:24271) is a protein-coding gene on chromosome 10q24.2, encoding Copper homeostasis protein cutC homolog (Q9NTM9). May play a role in copper homeostasis.
Members of the CUT family of copper transporters are associated with copper homeostasis and are involved in the uptake, storage, delivery, and efflux of copper (Gupta et al., 1995 [PubMed 7635807]; Li et al., 2005 [PubMed 16182249]).
Source: NCBI Gene 51076 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 56 total
- MANE Select transcript:
NM_015960
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24271 |
| Approved symbol | CUTC |
| Name | cutC copper transporter |
| Location | 10q24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CGI-32 |
| Ensembl gene | ENSG00000119929 |
| Ensembl biotype | protein_coding |
| OMIM | 610101 |
| Entrez | 51076 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 11 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000370472, ENST00000370476, ENST00000471520, ENST00000493385, ENST00000853283, ENST00000853284, ENST00000853285, ENST00000853286, ENST00000853287, ENST00000853288, ENST00000853289, ENST00000853290, ENST00000968212
RefSeq mRNA: 1 — MANE Select: NM_015960
NM_015960
CCDS: CCDS7483
Canonical transcript exons
ENST00000370476 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000719678 | 99743153 | 99743362 |
| ENSE00000719686 | 99747257 | 99747390 |
| ENSE00001020182 | 99744037 | 99744072 |
| ENSE00001020185 | 99750369 | 99750396 |
| ENSE00001452813 | 99755625 | 99756134 |
| ENSE00001452815 | 99732234 | 99732409 |
| ENSE00003522076 | 99754529 | 99754634 |
| ENSE00003587758 | 99739710 | 99739769 |
| ENSE00003638058 | 99736246 | 99736317 |
Expression profiles
Bgee: expression breadth ubiquitous, 275 present calls, max score 99.04.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 23.5114 / max 351.8301, expressed in 1817 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 106500 | 23.5114 | 1817 |
Top tissues by expression
286 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 99.04 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 98.64 | gold quality |
| biceps brachii | UBERON:0001507 | 98.60 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 98.37 | gold quality |
| gastrocnemius | UBERON:0001388 | 98.33 | gold quality |
| vastus lateralis | UBERON:0001379 | 98.27 | gold quality |
| quadriceps femoris | UBERON:0001377 | 98.21 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 98.16 | gold quality |
| muscle organ | UBERON:0001630 | 98.15 | gold quality |
| muscle of leg | UBERON:0001383 | 98.12 | gold quality |
| deltoid | UBERON:0001476 | 97.75 | gold quality |
| triceps brachii | UBERON:0001509 | 97.75 | gold quality |
| gluteal muscle | UBERON:0002000 | 97.67 | gold quality |
| diaphragm | UBERON:0001103 | 96.78 | gold quality |
| tibialis anterior | UBERON:0001385 | 96.11 | gold quality |
| body of tongue | UBERON:0011876 | 95.85 | gold quality |
| muscle tissue | UBERON:0002385 | 94.96 | gold quality |
| left testis | UBERON:0004533 | 93.65 | gold quality |
| right testis | UBERON:0004534 | 93.32 | gold quality |
| apex of heart | UBERON:0002098 | 92.95 | gold quality |
| testis | UBERON:0000473 | 92.71 | gold quality |
| heart left ventricle | UBERON:0002084 | 92.55 | gold quality |
| cardiac ventricle | UBERON:0002082 | 92.29 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 92.20 | gold quality |
| mucosa of stomach | UBERON:0001199 | 91.67 | gold quality |
| oocyte | CL:0000023 | 91.48 | gold quality |
| tibial nerve | UBERON:0001323 | 91.24 | gold quality |
| heart | UBERON:0000948 | 90.57 | gold quality |
| adipose tissue | UBERON:0001013 | 90.55 | gold quality |
| right atrium auricular region | UBERON:0006631 | 90.40 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-100618 | no | 427.30 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): E2F4
miRNA regulators (miRDB)
35 targeting CUTC, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-552-5P | 99.93 | 68.56 | 1583 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-221-5P | 99.86 | 65.45 | 1052 |
| HSA-MIR-8073 | 99.86 | 65.21 | 1118 |
| HSA-MIR-3681-5P | 99.82 | 66.88 | 387 |
| HSA-MIR-205-5P | 99.81 | 70.05 | 1557 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-320A-3P | 99.77 | 69.73 | 2107 |
| HSA-MIR-320B | 99.77 | 69.73 | 2107 |
| HSA-MIR-320C | 99.77 | 69.73 | 2107 |
| HSA-MIR-320D | 99.77 | 69.73 | 2107 |
| HSA-MIR-4429 | 99.77 | 69.62 | 2111 |
| HSA-MIR-6849-5P | 99.64 | 66.00 | 352 |
| HSA-MIR-302B-5P | 99.50 | 69.49 | 1857 |
| HSA-MIR-302D-5P | 99.50 | 69.34 | 1863 |
| HSA-MIR-4452 | 99.50 | 68.45 | 1493 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-593-3P | 99.22 | 67.28 | 1327 |
| HSA-MIR-1253 | 99.12 | 67.08 | 1688 |
| HSA-MIR-181A-2-3P | 98.91 | 67.60 | 1168 |
| HSA-MIR-3190-5P | 98.87 | 64.89 | 1345 |
| HSA-MIR-6895-3P | 98.79 | 65.69 | 996 |
| HSA-MIR-6509-3P | 98.32 | 67.33 | 1343 |
| HSA-MIR-653-3P | 98.31 | 67.71 | 1542 |
| HSA-MIR-4724-3P | 97.57 | 67.31 | 785 |
| HSA-MIR-219B-3P | 97.31 | 66.96 | 672 |
Literature-anchored findings (GeneRIF, showing 3)
- Cloning, expression and subcellular localization of CutC. (PMID:16182249)
- Results suggest that hCutC functions as an enzyme with Cu(I) as a cofactor rather than a copper transporter and the potential Cu(I)-binding site consists of the two Cys residues and other conserved residues in the vicinity. (PMID:19878721)
- present study reveals copper induced damage in cells upon hCutC silencing and provides evidence for the role of hCutC protein in intracellular copper homeostasis (PMID:26660891)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cutc | ENSDARG00000077306 |
| mus_musculus | Cutc | ENSMUSG00000025193 |
| rattus_norvegicus | Cutc | ENSRNOG00000017298 |
| drosophila_melanogaster | CG6136 | FBGN0038332 |
| caenorhabditis_elegans | WBGENE00022702 |
Protein
Protein identifiers
Copper homeostasis protein cutC homolog — Q9NTM9 (reviewed: Q9NTM9)
All UniProt accessions (3): Q9NTM9, A0A0B4J226, Q5TCZ7
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in copper homeostasis. Can bind one Cu(1+) per subunit.
Subunit / interactions. Homotetramer.
Subcellular location. Cytoplasm. Nucleus.
Tissue specificity. Ubiquitous.
Similarity. Belongs to the CutC family.
RefSeq proteins (1): NP_057044* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005627 | CutC-like | Family |
| IPR036822 | CutC-like_dom_sf | Homologous_superfamily |
Pfam: PF03932
UniProt features (31 total): strand 12, helix 10, turn 3, mutagenesis site 2, sequence conflict 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 3IWP | X-RAY DIFFRACTION | 2.5 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NTM9-F1 | 91.70 | 0.86 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 31 | reduces copper binding. reduces copper binding by 75%; when associated with a-52. |
| 52 | reduces copper binding. reduces copper binding by 75%; when associated with a-31. |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-936837 | Ion transport by P-type ATPases |
MSigDB gene sets: 136 (showing top):
GOBP_TRANSITION_METAL_ION_TRANSPORT, GOBP_COPPER_ION_TRANSPORT, GOBP_MONOATOMIC_CATION_TRANSPORT, WEI_MYCN_TARGETS_WITH_E_BOX, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, GOBP_MONOATOMIC_ION_HOMEOSTASIS, NRF2_01, GOBP_COPPER_ION_HOMEOSTASIS, GOBP_PROTEIN_TETRAMERIZATION, GOBP_HOMEOSTATIC_PROCESS, GOBP_CHEMICAL_HOMEOSTASIS, GOCC_NUCLEOLUS, SCGGAAGY_ELK1_02, MGGAAGTG_GABP_B
GO Biological Process (3): copper ion transport (GO:0006825), protein tetramerization (GO:0051262), copper ion homeostasis (GO:0055070)
GO Molecular Function (3): copper ion binding (GO:0005507), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (5): nucleus (GO:0005634), nucleoplasm (GO:0005654), nucleolus (GO:0005730), cytoplasm (GO:0005737), cytosol (GO:0005829)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Ion channel transport | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| nuclear lumen | 2 |
| transition metal ion transport | 1 |
| protein complex oligomerization | 1 |
| monoatomic cation homeostasis | 1 |
| inorganic ion homeostasis | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular membraneless organelle | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
768 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CUTC | CUTA | O60888 | 736 |
| CUTC | FMO3 | P31513 | 632 |
| CUTC | KRT74 | Q7RTS7 | 522 |
| CUTC | ARSH | Q5FYA8 | 510 |
| CUTC | YBEY | P58557 | 509 |
| CUTC | CUEDC1 | Q9NWM3 | 474 |
| CUTC | ATOX1 | O00244 | 468 |
| CUTC | ENTPD7 | Q9NQZ7 | 436 |
| CUTC | ATP7B | P35670 | 406 |
| CUTC | COPB1 | P53618 | 398 |
| CUTC | COMMD1 | Q8N668 | 395 |
| CUTC | KRT82 | Q9NSB4 | 394 |
| CUTC | CLPP | Q16740 | 393 |
| CUTC | COX11 | Q9Y6N1 | 391 |
| CUTC | TAAR5 | O14804 | 390 |
IntAct
63 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SPG21 | CUTC | psi-mi:“MI:0915”(physical association) | 0.780 |
| CUTC | SPG21 | psi-mi:“MI:0915”(physical association) | 0.780 |
| CUTC | SDCBP | psi-mi:“MI:0915”(physical association) | 0.720 |
| SDCBP | CUTC | psi-mi:“MI:0915”(physical association) | 0.720 |
| NADSYN1 | CUTC | psi-mi:“MI:0915”(physical association) | 0.670 |
| CUTC | BCL6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CEP76 | CUTC | psi-mi:“MI:0915”(physical association) | 0.560 |
| CUTC | GCD7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GCD7 | CUTC | psi-mi:“MI:0915”(physical association) | 0.560 |
| CUTC | XPO7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KANK2 | CUTC | psi-mi:“MI:0915”(physical association) | 0.560 |
| MEOX2 | CUTC | psi-mi:“MI:0915”(physical association) | 0.560 |
| PICK1 | CUTC | psi-mi:“MI:0915”(physical association) | 0.560 |
| ATXN1 | CUTC | psi-mi:“MI:0915”(physical association) | 0.560 |
| CDC37 | CUTC | psi-mi:“MI:0915”(physical association) | 0.560 |
| NTAQ1 | CUTC | psi-mi:“MI:0915”(physical association) | 0.560 |
| MESD | CUTC | psi-mi:“MI:0915”(physical association) | 0.560 |
| CUTC | CUTC | psi-mi:“MI:0915”(physical association) | 0.550 |
BioGRID (40): CUTC (Two-hybrid), CUTC (Two-hybrid), CUTC (Two-hybrid), SPG21 (Two-hybrid), CEP76 (Two-hybrid), LNX1 (Two-hybrid), CUTC (Two-hybrid), NADSYN1 (Two-hybrid), CUTC (Two-hybrid), SPG21 (Two-hybrid), NIF3L1 (Two-hybrid), NUDT18 (Two-hybrid), CUTC (Affinity Capture-RNA), CUTC (Two-hybrid), CUTC (Two-hybrid)
ESM2 similar proteins: A0RBL2, A4IPP2, A4WBM9, A6T4L2, A7GMU1, A7Z2G6, A9MUB2, A9VLG7, B1YLS2, B4SVF7, B4T805, B4TYT0, B4U2K6, B5BH48, B5F3I3, B5FSM4, B5R144, B5R8D0, B5XPZ4, B5Y1W9, B7JFY5, B9IUZ0, C0MGL4, C1EMA9, C3L9Q7, C3P4Z6, C5D2V7, C6DFE1, D2QS27, O32179, P35146, P36923, P73618, Q03LH6, Q21VV5, Q3A2I0, Q5KY94, Q5M0M2, Q5M558, Q5P8W0
Diamond homologs: A1AC35, A1JRM5, A4TJL0, A4WBM9, A5F8U2, A6L8P3, A6TB41, A6UF02, A7FID5, A7MT89, A7ZN00, A8A176, A8AFG8, A8GFJ9, A9MUB2, A9QYY3, B0RQ55, B0URL9, B1J0L4, B1JLM0, B1LCZ7, B1XHE2, B2K314, B2RIS4, B2U4X5, B2VJB9, B4ETN7, B4SVF7, B4T805, B4TYT0, B5BH48, B5F3I3, B5F9Z0, B5FSM4, B5R144, B5R8D0, B5XPZ4, B5YR19, B6EK72, B6I1F2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
56 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 40 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2463 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:99704540:ATCCT:A | acceptor_gain | 1.0000 |
| 10:99716458:TTCC:T | acceptor_gain | 1.0000 |
| 10:99716459:TCC:T | acceptor_gain | 1.0000 |
| 10:99716459:TCCC:T | acceptor_loss | 1.0000 |
| 10:99716460:CC:C | acceptor_gain | 1.0000 |
| 10:99716460:CCC:C | acceptor_gain | 1.0000 |
| 10:99716461:CC:C | acceptor_gain | 1.0000 |
| 10:99716462:C:CC | acceptor_gain | 1.0000 |
| 10:99716462:CTGC:C | acceptor_loss | 1.0000 |
| 10:99716463:T:A | acceptor_loss | 1.0000 |
| 10:99721064:GGCAA:G | acceptor_gain | 1.0000 |
| 10:99721066:CAA:C | acceptor_gain | 1.0000 |
| 10:99721069:C:CC | acceptor_gain | 1.0000 |
| 10:99721070:T:C | acceptor_loss | 1.0000 |
| 10:99721075:A:C | acceptor_gain | 1.0000 |
| 10:99724122:CC:C | acceptor_gain | 1.0000 |
| 10:99724123:CC:C | acceptor_gain | 1.0000 |
| 10:99724134:C:CT | acceptor_gain | 1.0000 |
| 10:99724134:C:T | acceptor_gain | 1.0000 |
| 10:99724135:A:T | acceptor_gain | 1.0000 |
| 10:99727433:ATACT:A | donor_loss | 1.0000 |
| 10:99727434:TACTT:T | donor_loss | 1.0000 |
| 10:99727435:ACTT:A | donor_loss | 1.0000 |
| 10:99727436:CTT:C | donor_loss | 1.0000 |
| 10:99727437:TTA:T | donor_loss | 1.0000 |
| 10:99727438:TACA:T | donor_loss | 1.0000 |
| 10:99727439:A:AC | donor_gain | 1.0000 |
| 10:99727440:C:CA | donor_loss | 1.0000 |
| 10:99727440:C:CG | donor_gain | 1.0000 |
| 10:99727440:CA:C | donor_gain | 1.0000 |
AlphaMissense
1744 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:99743224:T:C | F89L | 0.997 |
| 10:99743226:T:A | F89L | 0.997 |
| 10:99743226:T:G | F89L | 0.997 |
| 10:99736297:C:A | A38D | 0.996 |
| 10:99736305:G:C | A41P | 0.996 |
| 10:99739719:G:C | R48P | 0.996 |
| 10:99754591:C:G | H222D | 0.996 |
| 10:99736296:G:C | A38P | 0.995 |
| 10:99744070:G:C | R146P | 0.995 |
| 10:99747335:G:A | G173E | 0.995 |
| 10:99736284:T:C | S34P | 0.994 |
| 10:99739726:A:C | E50D | 0.994 |
| 10:99739726:A:T | E50D | 0.994 |
| 10:99743309:G:A | G117E | 0.993 |
| 10:99747262:G:C | D149H | 0.993 |
| 10:99747326:T:C | L170S | 0.993 |
| 10:99747358:G:T | G181W | 0.993 |
| 10:99754538:T:A | I204K | 0.993 |
| 10:99744066:C:G | H145D | 0.992 |
| 10:99747380:T:C | L188P | 0.992 |
| 10:99736277:T:G | C31W | 0.991 |
| 10:99736306:C:A | A41E | 0.991 |
| 10:99739728:T:C | L51S | 0.991 |
| 10:99739763:A:C | S63R | 0.991 |
| 10:99739765:C:A | S63R | 0.991 |
| 10:99739765:C:G | S63R | 0.991 |
| 10:99743213:G:C | R85P | 0.991 |
| 10:99743225:T:C | F89S | 0.991 |
| 10:99747263:A:C | D149A | 0.991 |
| 10:99747263:A:T | D149V | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000008782 (10:99738468 A>G), RS1000205963 (10:99733181 C>T), RS1000236663 (10:99745237 T>C,G), RS1000247549 (10:99738160 T>A,C), RS1000334891 (10:99752869 A>G), RS1000337477 (10:99752669 G>A,T), RS1000370250 (10:99752341 C>T), RS1000372928 (10:99752553 C>G), RS1000478160 (10:99745627 G>T), RS1000489489 (10:99732367 T>C,G), RS1000498503 (10:99744258 T>C), RS1000584849 (10:99736612 A>C,T), RS1001025360 (10:99740637 C>G,T), RS1001033047 (10:99733512 C>G), RS1001167366 (10:99753226 A>C)
Disease associations
OMIM: gene MIM:610101 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001438_10 | Crohn’s disease | 5.000000e-07 |
| GCST001762_86 | Obesity-related traits | 6.000000e-06 |
| GCST003017_4 | Colorectal cancer | 8.000000e-07 |
| GCST003017_9 | Colorectal cancer | 4.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004611 | low density lipoprotein cholesterol measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
37 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 2 |
| Dexamethasone | increases expression, affects cotreatment | 2 |
| Fluorouracil | affects response to substance, affects reaction, decreases expression | 2 |
| Copper Sulfate | decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects cotreatment, increases expression | 1 |
| trichostatin A | affects expression | 1 |
| K 7174 | decreases expression | 1 |
| ICG 001 | decreases expression | 1 |
| abrine | decreases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Quercetin | decreases expression | 1 |
| Selenium | affects cotreatment, increases expression, decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B1PM | Abcam HeLa CUTC KO | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.